Literature DB >> 27327871

Temperature Control in Rodent Neuroprotection Studies: Methods and Challenges.

Ana C Klahr1, Colby A Nadeau2, Frederick Colbourne1,2.   

Abstract

Extensive animal research facilitated the clinical translation of therapeutic hypothermia for cardiac arrest in adults and hypoxic-ischemic injury in infants. Similarly, clinical interest in hypothermia for other brain injuries, such as stroke, has been greatly supported by positive findings in preclinical work. The reliability, validity, and utility of animal models, among many research practices (blinding, randomization, etc.), are key to successful clinical translation. Here, we review methods used to induce and maintain hypothermia in animal models. These include physical and pharmacological methods. We emphasize the advantages and limitations of each approach, and the importance of using clinically relevant cooling protocols and appropriate monitoring and reporting approaches. Moreover, we performed a literature survey of ischemic stroke studies published in 2015 to highlight the continuing risk of temperature confounds in neuroprotection studies. For example, many still do not accurately monitor and report temperature during surgery (23.5%), even though almost half of these studies (46.0%) use pharmaceutical agents that likely influence temperature. We hope this review stimulates awareness and discussion of the importance of temperature in neuroprotective studies.

Entities:  

Keywords:  hypothermia; method; neuroprotection; review; rodents; temperature

Mesh:

Year:  2016        PMID: 27327871     DOI: 10.1089/ther.2016.0018

Source DB:  PubMed          Journal:  Ther Hypothermia Temp Manag        ISSN: 2153-7658            Impact factor:   1.286


  6 in total

1.  Optimization of Thermolytic Response to A1 Adenosine Receptor Agonists in Rats.

Authors:  Isaac R Bailey; Bernard Laughlin; Lucille A Moore; Lori K Bogren; Zeinab Barati; Kelly L Drew
Journal:  J Pharmacol Exp Ther       Date:  2017-06-26       Impact factor: 4.030

2.  Neuroprotective effects of inter-alpha inhibitor proteins after hypoxic-ischemic brain injury in neonatal rats.

Authors:  Xiaodi Chen; Sakura Nakada; John E Donahue; Ray H Chen; Richard Tucker; Joseph Qiu; Yow-Pin Lim; Edward G Stopa; Barbara S Stonestreet
Journal:  Exp Neurol       Date:  2019-03-23       Impact factor: 5.330

3.  Inter-alpha Inhibitor Proteins Ameliorate Brain Injury and Improve Behavioral Outcomes in a Sex-Dependent Manner After Exposure to Neonatal Hypoxia Ischemia in Newborn and Young Adult Rats.

Authors:  Xiaodi Chen; Jiyong Zhang; Yuqi Wu; Richard Tucker; Grayson L Baird; Rose Domonoske; Adriel Barrios-Anderson; Yow-Pin Lim; Kevin Bath; Edward G Walsh; Barbara S Stonestreet
Journal:  Neurotherapeutics       Date:  2022-03-15       Impact factor: 6.088

Review 4.  Experimental Models for Testing the Efficacy of Pharmacological Treatments for Neonatal Hypoxic-Ischemic Encephalopathy.

Authors:  Elisa Landucci; Domenico E Pellegrini-Giampietro; Fabrizio Facchinetti
Journal:  Biomedicines       Date:  2022-04-19

5.  Glibenclamide, a Sur1-Trpm4 antagonist, does not improve outcome after collagenase-induced intracerebral hemorrhage.

Authors:  Cassandra M Wilkinson; Paul S Brar; Celine J Balay; Frederick Colbourne
Journal:  PLoS One       Date:  2019-05-01       Impact factor: 3.240

Review 6.  Molecular, Pathological, Clinical, and Therapeutic Aspects of Perihematomal Edema in Different Stages of Intracerebral Hemorrhage.

Authors:  Chao Jiang; Hengtao Guo; Zhiying Zhang; Yali Wang; Simon Liu; Jonathan Lai; Tom J Wang; Shize Li; Jing Zhang; Li Zhu; Peiji Fu; Jiewen Zhang; Jian Wang
Journal:  Oxid Med Cell Longev       Date:  2022-09-17       Impact factor: 7.310

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.